Why the study?
Does the expression of CaT-L correlate with prostate cancer malignancy?
Does the expression of CaT-L correlate with prostate cancer malignancy?
The human CaT-L channel represents a novel marker for prostate cancer progression and a potential therapeutic target.
No takes yet. Share an insight, caveat, or question.
CaT-L may mark prostate cancer progression in models; leaves open validation as biomarker or target in humans.
Wissenbach et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: